2016 annual financial data

Relmada Therapeutics 2016 Net margin

Relmada Therapeutics 2016 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -16,216,000 USD and net income was -2,975,000 USD.
Operating cash flow was -13,143,745 USD.

Get free Relmada Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-16,216,000 USD
Net income
-2,975,000 USD
Operating cash flow
-13,143,745 USD